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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S196Conclusions: Global gene expression analysis of dedifferentiated chon-
drocytes relative to native cartilage and other mesenchyme-derived tissue
would suggest that loss of functional phenotype in monolayer culture
encourages the up-regulation of genes associated with pre-hypertrophic
chondrocytes during development.
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A FUNCTIONAL INVESTIGATION OF A RARE VARIANT IN THE PROMOTER
OF THE OA-ASSOCIATED LOCUS GDF5 AND THE DISCOVERY OF A TRANS-
ACTING FACTOR INTERACTING WITH THE VARIANT SITE
A.W. Dodd, J. Loughlin. Newcastle Univ., Newcastle upon Tyne, United
Kingdom
Purpose: The rs143383 SNP within the 5'UTR of the growth/differentiation
factor 5 gene GDF5 is one of the most robust association signals for large-
joint OA. The SNPacts byaltering the level of GDF5 expression and this effect
is modulated by a second 5'UTR SNP, rs143384. We recently completed
adeep sequencingof the gene to identify novel rare variants thatmayalso be
functional, with one variant foundwithin the promoter of GDF5, -41bp from
the transcription start site. In this report we set out to determine what
functional effect this variant is having on GDF5 expression, including the
identiﬁcation of the trans-acting factors binding to the variant site.
Methods: A 403bp fragment encompassing the proximal promoter and
part of the 5'UTR of GDF5 was cloned into the pGL3 Basic Luciferase
reporter plasmid. Following molecular haplotyping, we created haplotype
combinations between the -41bp variant alleles and the rs143383 and
rs143384 alleles. We transfected these plasmids into SW1353 chon-
drosarcoma cells and into MG63 osteosarcoma cells and measured lucif-
erase activity. Electrophoretic mobility shift assays (EMSAs) were then
performed to identify the trans-acting factors binding to the -41bp variant,
and to compare their binding afﬁnity to the two variant alleles. A super-
shift assay, using a trans-factor speciﬁc antibody, was then carried out to
conﬁrm speciﬁc protein binding.
Results: The transfection experiment revealed that the mutant A-allele of
the -41bp variant mediated a signiﬁcant increase in gene expression
compared to the wildtype C-allele, independent of genotype at rs143383
or rs143384. The greatest difference between the -41bp alleles was
observed in the MG63 cell line, with a 36% increased expression of the
A-allele relative to the C-allele (p¼0.0009). Our EMSA and supershift
analyses revealed that the YY1 transcription factor binds to the variant site
and that this binding is more avid for the mutant A-allele, implying that
YY1 is an activator of GDF5 expression.
Conclusions: A variant discovered by deep sequencing of GDF5 has been
shown to be functional and to inﬂuence gene expression independent of
the common functional polymorphisms rs143383 and rs143384. The
variant increases expression by increasing the binding of the transcription
factor YY1. Our study has therefore identiﬁed a novel functional region of
this important OA susceptibility locus and revealed a trans-acting factor
that regulates GDF5 expression.
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CPG SITES OF OSTEOARTHRITIS SUSCEPTIBILITY GENE DIO2 ARE
DIFFERENTIALLY METHYLATED IN ARTHRITIC COMPARED TO
PRESERVED CARTILAGE.
W. den Hollander, S.D. Bos, Y.F. Ramos, N. Lakenberg, R. van der Breggen,
B.J. Duijnisveld, R.G. Nelissen, E.P. Slagboom, I. Meulenbelt. LUMC, Leiden,
Netherlands
Purpose: Through genome wide approaches genetic variation at deiodi-
nase iodothyronine type II (D2) gene (DIO2) was identiﬁed as compelling
osteoarthritis (OA) susceptibility gene. Furthermore, studies showed that
DIO2 gene expression is up regulated in osteoarthritic as compared to
healthy cartilage, which might be explained by an allelic imbalance of the
DIO2 mRNA in cartilage in which we observed aw30% higher presence of
the OA-associated C allele relative to the T allele of the intragenic DIO2 SNP
rs225014 in heterozygous carriers. In the current study, we investigate
whether the expression of DIO2 is modulated epigenetically by DNA
methylation at CpG dinucleotides in the promoter, in transcription factor
binding sites (TFBS) and/or in an intragenic putative CTCF binding site.Methods: We collected both preserved and osteoarthritic cartilage
(determined macroscopically) from OA patients undergoing total joint
arthroplasty (N¼26, age range 44-80 years) of the hip or knee. Cartilage
was snap frozen in liquid nitrogen and stored at -80 C. Using a Retsch
MM200 sample disintegrator cartilage was powderized prior to DNA and
RNA isolations. DNA was isolated using Promega Wizard Genomic DNA
Puriﬁcation kit and RNAwas isolated by trizol addition and Qiagen RNeasy
columns. Bisulﬁte treatment of isolated DNAwas performed with Zymo EZ
DNA Methylation kit. Eight amplicons covering 16 CpG dinucleotides were
designed using MethPrimer; amplicons were designed to encompass the
promoter, TFBSs and a putative CTCF binding site. Amplicons were PCR
ampliﬁed and quantitatively assessed for CpG methylation using a mass
spectrometry based method (Epityper, Sequenom). Statistical analysis was
performed using a two tailed, paired t-test.
Results: We examined the differences in methylation state of CpG dinu-
cleotides of DIO2 in matched OA affected and preserved cartilage samples.
Out of ﬁve amplicons analyzed thus far, at least three CpG dinucleotides
located in a TFBS upstream of the promoter, were differentially methylated
in preserved compared to arthritic cartilage (P¼0.002, P¼0.031 and
P¼0.023, paired t-tests). Of these, two CpG dinucleotides show a signiﬁ-
cant reduction in methylation, whereas one CpG sitewas hypermethylated
in osteoarthritic cartilage as compared to preserved cartilage.
Conclusions: Methylation states of CpG nucleotides located in TFBS
upstream of the DIO2 promotor differ signiﬁcantly between preserved
cartilage and osteoarthritic cartilage ex vivo. Follow up of the methylation
status of these CpGdinucleotides, in relation toDIO2 expression,will further
elucidate the putative regulatory properties. These preliminary analyses
indicate that there is a disease related differential methylation state of three
CpG dinucleotides located in essential DIO2 regulatory DNA motifs.
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THE MTDNA HAPLOGROUPS RELATED WITH THE MITOCHONDRIAL
UNCOUPLING MECHANISM ARE PROTECTIVE FACTORS AGAINST OA IN
SPAIN AND UK
A. Soto-Hermida, M. Fernández-Moreno, N. Oreiro-Villar, C. Fernández-
López, I. Rego-Pérez, F.J. Blanco. INIBIC-CHUAC. Rheumatology Div..
Genomic Group., A Coruña, SPAIN
Purpose: Oxidative stress and ROS production are key factors in the
development of OA. Some reports have shown that those mtDNA hap-
logroups related with the mild uncoupling of the mitochondrial oxidative
phosphorylation system (OXPHOS), such as haplogroups J and T, are less
prone to produce reactive oxygen species (ROS). Taking into account that
the mtDNA haplogroup J is a protective factor against OA in Spanish
populations, the aim of this work is to compare the frequency distribution
of the mtDNA haplogroups in OA patients and healthy controls between
United Kingdom (UK) and Spain.
Methods: We used the single base extension (SBE) assay combined with
polymerase chain reaction-restriction fragment length polymorphism
(PCR-RFLP) to obtain the European mtDNA haplogroups in 1471 OA
patients and 406 healthy controls from Spain, and 453 OA patients and 280
healthy controls from UK (samples kindly provide by Prof. J. Loughlin).
Some of the differential single nucleotide polymorphisms (SNPs) hap-
logroup J-related between both populations were also analyzed using the
SBE assay. The resulting frequencies were analyzed with SPSS software
(v.18) following appropriate statistical analyses.
Results: The mtDNA haplogroup J appeared signiﬁcantly underrepre-
sented in OA patients from the north of Spain when compared with
healthy controls (OR¼0.614; 95% CI: 0.426-0.884; p¼0.008). Individuals
from UK carrying the mtDNA haplogroup T showed a signiﬁcantly
decreased risk of OA (OR¼0.581; 95% CI: 0.365-0.926; p¼0.021). The
mtDNA haplogroup J bordered the statistical signiﬁcance towards
a decreased presence in healthy controls from UK (OR¼1.686; 95%
CI: 0.929-3.061; p¼0.083). The analysis of the differentially expressed
haplogroup J-related SNPs in Spain and UK, m.14798t>c, m.15257g>a and
m.3394t>c, showed that the SNP m.3394t>c (associated with uncoupling
of OXPHOS and with less production of ROS) appeared signiﬁcantly
underrepresented in the UK cohort (p¼0.029).
Conclusions: The mitochondrial uncoupling mechanism, derived from the
mtDNA haplogroups J and T, could be a protective factor against OA in
ĂAbstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S197Spain and UK populations. This association is probably due to a reduced
ROS production as a consequence of the climate adaptation of these
mtDNA haplogroups.
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A GENOME-WIDE EXPRESSIONOFHUMANARTICULAROSTEOARTHRITIC
CARTILAGE SHOWS DIFFERENT GENE-EXPRESSION PROFILES RELATED
TO BOTH INFLAMMATORY AND IMMUNE RESPONSE PROCESSES
J. Fernández-Tajes, A. Soto-Hermida, M. Fernández-Moreno, M.E. Vázquez-
Mosquera, N. Oreiro-Villar, C. Fernández-López, E. Cortés-Pereira,
S. Relaño-Fernández, I. Rego-Pérez, F.J. Blanco. INIBIC-CHUAC, Genomic
Group. Rheumatology Div.., A Coruña, Spain
Purpose: To perform a genome-wide expression assay in order to identify
different expression proﬁles in the OA disease
Methods: Total RNA from OA cartilage samples was isolated with RNeasy
Kit (Qiagen, Madrin, Spain) following manufacturer’s instructions. RNA
was checked for integrity and purity with the Agilent Bioanalyzer (Agilent
Technologies) and NanoDrop spectrophotometer (Thermo Scientiﬁc). 150
nanograms of total RNA were used for cDNA synthesis using the Ambion
WT Expression kit (Ambion). The fragmented cDNAwas hybridized against
the Human Gene 1.1 ST array strip (Affymetrix) and scanned using the
GeneTitan system (Affymetrix). Quality controls, normalization, pre-pro-
cessing, differential gene expression and functional analyses were carried
out with Bioconductor packages using R software.
Results: Human Gene 1.1 ST Array, which interrogates more than 28,000
well-annotated genes of 33,297 probes, was used for studying the genome
wide expression proﬁle of 23 OA-patients tissue samples. A non-speciﬁc
ﬁltering was previously applied for removing those probes with non-
annotation information and with low intra-array variation. An unsuper-
vised machine learning approach revealed a group of samples highly
different (Figure 1). The differential expression analysis between this
cluster, comprising a total of ﬁve OA-patients, and the rest of the samples
allowed for the identiﬁcation of 176 differentially expressed probes with
an adjusted p value below 0.0001. The 20 differentially expressed probes
with higher log Fold Change are presented in Table 1. The analysis of the
biological processes related to these differentially expressed genes showed
that inﬂammation and immune processes were the main pathways found
to be altered when a gene set enrichment analysis was applied.
Conclusions: The genome-wide expression analysis shows a clearly
distinct proﬁle for a group of OA patients. Both inﬂammation and immune
response processes appeared to be altered and therefore are revealed as
key factors in the development of the OA disease.Ă397
IDENTIFICATION OF THE PATHOGENIC PATHWAYS IN OSTEOARTHRITIC
HIP CARTILAGE: COMMONALITY AND DISCORD BETWEEN HIP AND
KNEE OA
Y. Xu, M.J. Barter, D.C. Swan, K.S. Rankin, A.D. Rowan, M. Santibanez-
Koref, J. Loughlin, D.A. Young. Newcastle Univ., Newcastle upon Tyne,
United Kingdom
Purpose: To deﬁne for the ﬁrst time the transcriptome of normal and end-
stage osteoarthritic (OA) hip cartilage and to identify novel pathogenic
pathways involved in the disease.
Methods: RNA was isolated from articular cartilage samples obtained from
consented patients undergoing joint replacement surgery due to either end-
stage hip OA or neck of femur fracture (NOF). Illumina HumanHT-12 V3
whole genome expression arrayswere used to proﬁle gene expressions. Raw
data was analyzed and differentially expressed genes identiﬁed using the
Agilent Gene Spring GX 11 package. P-values were corrected for multiple
testing using the Benjamini-Hochberg method. Gene Set Enrichment Anal-
ysis (GSEA) and Ingenuity Pathway Analysis (IPA) were used to investigate
functions and pathways associated with these genes, respectively. Protein
interaction networks were predicted using STRING and visualized with
Medusa 3.0. Differentially expressed genes were veriﬁed by real-time PCR.
Results: In total we identiﬁed 1151 differentially expressed genes (fold
change  -1.5 or 1.5, P-value  0.01) between NOF (n¼10) and OA hip
(n¼9) cartilage. Sixty canonical pathways (P-value  0.05) were identiﬁed
as associated with these genes. A comparison between a published
comparable knee dataset only identiﬁed 183 genes similarly differentially
expressed but remarkably 35 canonical pathways overlapped between the
experiments. wnt/b-catenin signalling, PI3K/AKT signalling and IL-17 sig-
nalling pathways were identiﬁed in common between both studies.
Pathways such as glycosaminoglycan degradation (P-value¼0.044), HIF1a
signalling (P-value¼0.007) and interferon signalling (P-value¼0.003),
were speciﬁc to our hip OA study, while IGF-1 signalling, clathrin-medi-
ated endocytosis signalling and HMGB1 signalling were only associated
with the differentially expressed genes from knee OA cartilage.
Conclusions: This is the ﬁrst study to report a comprehensive gene
expression analysis of human hip OA cartilage compared to control (neck
of femur fracture) cartilage at the whole human genome level. Our
differential gene expression dataset shows excellent correlation with
similar deﬁned studies using comparable tissue but reveals discord
between hip and knee OA in the behavior of individual genes although
commonality with respect to the molecular pathways involved.
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MICROARRAY ANALYSIS OF GENE EXPRESSION IN PRIMARY HUMAN
OSTEOBLASTS DERIVED FROM SPINE
F. Moldovan, K. Fendri, S. Parent, C. Zaouter, A. Moreau,
K.S. Patten. Montreal Univ., Montreal, QC, Canada
